December 23, 2024 11:17 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle
DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute

Aug 03, 2020, at 11:13 pm

New Delhi: The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine.